Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$220,320
-$1,357,145 QoQ
Shares Held
36,000
-79.9% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 172 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0%
Shared 68%
None 32%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. VNDA ranks #199 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in VNDA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $220,320 | 36,000 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $1,577,465 | 178,851 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $943,343 | 189,047 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,380,574 | 292,495 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,220,425 | 265,888 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,670,971 | 348,846 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,452,262 | 309,651 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,066,532 | 365,758 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,791,002 | 435,767 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $794,006 | 183,798 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,373,283 | 208,389 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $123,801 | 11,358 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $128,458 | 11,358 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $186,224 | 11,869 | Shares | Defined | 2022-02-11 | |
| 2021-06-30 ALXN | — | 44,922 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 ALXN | — | 49,359 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 ALXN | — | 185,521 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 ALXN | — | 26,079 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 ALXN | — | 12,944 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 ALXN | — | 14,077 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||